Many other studies (including metabolomics approaches, miRNA and exosomes analyses) are currently ongoing to evaluate the diagnostic significance of blood-based or even urine-based AD biomarkers, including the last described proteins SPP1, GSN, and IGFBP7 that were found to be differentially expressed in the urine of AD patients compared to healthy subjects [117,118,119,120,121,122]. Here, IGFBP7 is linked to Alzheimer disease.